학술논문

FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 1 September 2023, 41(25):4143-4153)
Subject
Language
English
ISSN
15277755
0732183X